Erik L. Kimble
- Co-authors
- Krishna V. KomanduriJosé F. CamargoCara L. BenjaminEric WiederJuan Pablo AlderuccioJeremy RamdialIsildinha M. ReisNicolas Gallastegui
- Topics
- CAR-T cell therapy research (20 papers)Biosimilars and Bioanalytical Methods (5 papers)Cytomegalovirus and herpesvirus research (5 papers)
- Journals
- Nature CommunicationsJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- United StatesAustraliaSwitzerland
In The Last Decade
Erik L. Kimble
26 papers receiving 217 citations
Peers
Comparison fields: 5 of 33
- Oncology 106
- Epidemiology 89
- Pathology and Forensic Medicine 82
- Immunology 39
- Genetics 37
Countries citing papers authored by Erik L. Kimble
This map shows the geographic impact of Erik L. Kimble's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik L. Kimble with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik L. Kimble more than expected).
Fields of papers citing papers by Erik L. Kimble
This network shows the impact of papers produced by Erik L. Kimble. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik L. Kimble. The network helps show where Erik L. Kimble may publish in the future.
Co-authorship network of co-authors of Erik L. Kimble
This figure shows the co-authorship network connecting the top 25 collaborators of Erik L. Kimble. A scholar is included among the top collaborators of Erik L. Kimble based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik L. Kimble. Erik L. Kimble is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 5 | |
| 5 | 4 | |
| 6 | 7 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 0 | |
| 10 | 14 | |
| 11 | 2 | |
| 12 | 2 | |
| 13 | 0 | |
| 14 | 4 | |
| 15 | 26 | |
| 16 | 47 | |
| 17 | 36 | |
| 18 | 49 | |
| 19 | 2 | |
| 20 | 1 |
About Erik L. Kimble
Erik L. Kimble is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine, having authored 31 papers that have together received 218 indexed citations. Recurring topics across this work include CAR-T cell therapy research (20 papers), Biosimilars and Bioanalytical Methods (5 papers) and Cytomegalovirus and herpesvirus research (5 papers). The work is most often cited by research in Pathology and Forensic Medicine (82 citations), Oncology (106 citations) and Genetics (37 citations). Erik L. Kimble has collaborated with scholars based in United States, Australia and Switzerland. Frequent co-authors include Krishna V. Komanduri, José F. Camargo, Cara L. Benjamin, Eric Wieder, Juan Pablo Alderuccio, Jeremy Ramdial, Isildinha M. Reis, Nicolas Gallastegui, Jennifer R. Chapman and Amrita Desai. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.